Clinical Therapeutics Q2 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

NA

Clinical Therapeutics focuses its scope in these topics and keywords: chinese, healthy, pharmacokinetics, review, treatment, patients, randomized, coronary, parallel, suspension, ...

Type: Journal

Type of Copyright: NA

Languages: English

Open Access Policy: NA

Type of publications: NA

Publication frecuency: NA

Price

NA €

Gold OA

-

Green OA

NA €

Non OA

Metrics

Clinical Therapeutics

0,981

SJR Impact factor

134

H Index

223

Total Docs (Last Year)

672

Total Docs (3 years)

9030

Total Refs

1766

Total Cites (3 years)

587

Citable Docs (3 years)

2,33

Cites/Doc (2 years)

40,49

Ref/Doc

Aims and Scope


chinese, healthy, pharmacokinetics, review, treatment, patients, randomized, coronary, parallel, suspension, combination, administered, gastrointestinal, drug, tolerability, assessment, alzheimer’s, amyloidosis, analogrelated, anniversary, asthma, anticoagulants, antimicrobial, antiretroviral, antiviral, NA


Best articles

A cost-of-illness study of lyme disease in the United States

View more

A disease management case study in infectious disease

View more

A disease management case study on asthma

View more

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

View more

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients

View more

A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy

View more

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients

View more

Amlodipine, felodipine, and isradipine in the treatment of chinese patients with mild-to-moderate hypertension

View more

An estradiol matrix transdermal system for the prevention of postmenopausal bone loss

View more

An immunophilin-binding assay for sirolimus

View more

An outpatient prescription-medication benefit in medicare: So much time, so little consensus

View more

Assessing the input costs of disease management programs

View more
SHOW MORE ARTICLES

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe

View more

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension

View more

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients

View more

Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone

View more

Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness

View more

Clinical efficacy of dirithromycin in patients with bacteremic pneumonia

View more

Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain

View more

Combined metformin and insulin therapy for patients with type 2 diabetes mellitus

View more

Comparative bioavailability of ceftibuten in capsule and suspension forms

View more

Comparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy

View more

Compliance of pediatric patients with treatment involving antibiotic suspensions: A pilot study

View more

Disease management contracting: legal issues

View more

Comments

No comments ... Be the first to comment!